{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-288703","form_type":"8-K","ticker":"LXEO","cik":"0001907108","company_name":"Lexeo Therapeutics, Inc.","filed_at":"2026-06-29T21:06:22+00:00","discovered_at":"2026-06-29T21:08:00.353896+00:00","generated_at":"2026-06-29T21:08:27.506126+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Lexeo Therapeutics reports 2026 annual meeting results; all director nominees elected","bullets":["Elected Class III directors Townsend (64.7M FOR), Cooperstone (48.8M FOR), and Cholmondeley (64.7M FOR); broker non-votes ~10M each.","Ratified KPMG as independent auditor for fiscal 2026: 75.5M FOR, 55.6K AGAINST, 30.1K abstain.","Annual Meeting held virtually on June 25, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-288703","json":"https://secwatch.observer/filing/0001193125-26-288703.json","markdown":"https://secwatch.observer/filing/0001193125-26-288703.md","text":"https://secwatch.observer/filing/0001193125-26-288703.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526288703/0001193125-26-288703-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526288703/lxeo-20260625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:08:27.506126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}